UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 7, 2013 5:00 P.M.

Form:	S-1
CIK: 0001360214 Company Name: Imprimis Pharmaceuticals, Inc. File Number: 333-182846